142 related articles for article (PubMed ID: 6420445)
1. The effects of naloxone on hot flashes and gonadotropin secretion in postmenopausal women.
DeFazio J; Verheugen C; Chetkowski R; Nass T; Judd HL; Meldrum DR
J Clin Endocrinol Metab; 1984 Mar; 58(3):578-81. PubMed ID: 6420445
[TBL] [Abstract][Full Text] [Related]
2. Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist.
DeFazio J; Meldrum DR; Laufer L; Vale W; Rivier J; Lu JK; Judd HL
J Clin Endocrinol Metab; 1983 Mar; 56(3):445-8. PubMed ID: 6401756
[TBL] [Abstract][Full Text] [Related]
3. LH, FSH and skin temperaure during the menopausal hot flash.
Tataryn IV; Meldrum DR; Lu KH; Frumar AM; Judd HL
J Clin Endocrinol Metab; 1979 Jul; 49(1):152-4. PubMed ID: 447814
[TBL] [Abstract][Full Text] [Related]
4. Effect of clonidine on hot flashes in postmenopausal women.
Laufer LR; Erlik Y; Meldrum DR; Judd HL
Obstet Gynecol; 1982 Nov; 60(5):583-6. PubMed ID: 7145250
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous opioid peptides in the initiation of the midcycle luteinizing hormone surge in normal cycling women.
Rossmanith WG; Mortola JF; Yen SS
J Clin Endocrinol Metab; 1988 Oct; 67(4):695-700. PubMed ID: 3138276
[TBL] [Abstract][Full Text] [Related]
6. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
Gindoff PR; Ferin M
Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
[TBL] [Abstract][Full Text] [Related]
7. Climacteric flushing: clinical and endocrine response to infusion of naloxone.
Lightman SL; Jacobs HS; Maguire AK; McGarrick G; Jeffcoate SL
Br J Obstet Gynaecol; 1981 Sep; 88(9):919-24. PubMed ID: 6791684
[TBL] [Abstract][Full Text] [Related]
8. Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women.
Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
Neuroendocrinology; 2018; 106(2):148-157. PubMed ID: 28380486
[TBL] [Abstract][Full Text] [Related]
9. Objectively recorded hot flushes in patients with pituitary insufficiency.
Meldrum DR; Erlik Y; Lu JK; Judd HL
J Clin Endocrinol Metab; 1981 Apr; 52(4):684-8. PubMed ID: 6782116
[TBL] [Abstract][Full Text] [Related]
10. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
[TBL] [Abstract][Full Text] [Related]
11. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
[TBL] [Abstract][Full Text] [Related]
13. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
14. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
[TBL] [Abstract][Full Text] [Related]
15. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis.
Lanfranco F; Bonelli L; Baldi M; Me E; Broglio F; Ghigo E
J Clin Endocrinol Metab; 2008 Sep; 93(9):3633-9. PubMed ID: 18559917
[TBL] [Abstract][Full Text] [Related]
16. Effect of sodium valproate on luteinizing hormone secretion in pre- and postmenopausal women and its modulation by naloxone infusion.
Popovic V; Spremovic-Radjenovic S; Eric-Marinkovic J; Grossman A
J Clin Endocrinol Metab; 1996 Jul; 81(7):2520-4. PubMed ID: 8675571
[TBL] [Abstract][Full Text] [Related]
17. Opiatergic control of gonadotropin secretion during puberty in the rat: a neurochemical basis for the hypothalamic 'gonadostat'?
Bhanot R; Wilkinson M
Endocrinology; 1983 Aug; 113(2):596-603. PubMed ID: 6409589
[TBL] [Abstract][Full Text] [Related]
18. The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women.
Reid RL; Quigley ME; Yen SS
J Clin Endocrinol Metab; 1983 Dec; 57(6):1107-10. PubMed ID: 6313728
[TBL] [Abstract][Full Text] [Related]
19. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
[TBL] [Abstract][Full Text] [Related]
20. Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease.
Cagnacci A; Melis GB; Soldani R; Bonuccelli U; Piccini P; Napolitano A; Muratorio A; Fioretti P
Neuroendocrinology; 1991 Jun; 53(6):549-55. PubMed ID: 1678880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
